Literature DB >> 21763482

VPS35 mutations in Parkinson disease.

Carles Vilariño-Güell1, Christian Wider, Owen A Ross, Justus C Dachsel, Jennifer M Kachergus, Sarah J Lincoln, Alexandra I Soto-Ortolaza, Stephanie A Cobb, Greggory J Wilhoite, Justin A Bacon, Bahareh Behrouz, Heather L Melrose, Emna Hentati, Andreas Puschmann, Daniel M Evans, Elizabeth Conibear, Wyeth W Wasserman, Jan O Aasly, Pierre R Burkhard, Ruth Djaldetti, Joseph Ghika, Faycal Hentati, Anna Krygowska-Wajs, Tim Lynch, Eldad Melamed, Alex Rajput, Ali H Rajput, Alessandra Solida, Ruey-Meei Wu, Ryan J Uitti, Zbigniew K Wszolek, François Vingerhoets, Matthew J Farrer.   

Abstract

The identification of genetic causes for Mendelian disorders has been based on the collection of multi-incident families, linkage analysis, and sequencing of genes in candidate intervals. This study describes the application of next-generation sequencing technologies to a Swiss kindred presenting with autosomal-dominant, late-onset Parkinson disease (PD). The family has tremor-predominant dopa-responsive parkinsonism with a mean onset of 50.6 ± 7.3 years. Exome analysis suggests that an aspartic-acid-to-asparagine mutation within vacuolar protein sorting 35 (VPS35 c.1858G>A; p.Asp620Asn) is the genetic determinant of disease. VPS35 is a central component of the retromer cargo-recognition complex, is critical for endosome-trans-golgi trafficking and membrane-protein recycling, and is evolutionarily highly conserved. VPS35 c.1858G>A was found in all affected members of the Swiss kindred and in three more families and one patient with sporadic PD, but it was not observed in 3,309 controls. Further sequencing of familial affected probands revealed only one other missense variant, VPS35 c.946C>T; (p.Pro316Ser), in a pedigree with one unaffected and two affected carriers, and thus the pathogenicity of this mutation remains uncertain. Retromer-mediated sorting and transport is best characterized for acid hydrolase receptors. However, the complex has many types of cargo and is involved in a diverse array of biologic pathways from developmental Wnt signaling to lysosome biogenesis. Our study implicates disruption of VPS35 and retromer-mediated trans-membrane protein sorting, rescue, and recycling in the neurodegenerative process leading to PD.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763482      PMCID: PMC3135796          DOI: 10.1016/j.ajhg.2011.06.001

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

1.  Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study.

Authors:  Shannon K McDonnell; Daniel J Schaid; Alexis Elbaz; Kari J Strain; James H Bower; J Eric Ahlskog; Demetrius M Maraganore; Walter A Rocca
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

2.  Functional architecture of the retromer cargo-recognition complex.

Authors:  Aitor Hierro; Adriana L Rojas; Raul Rojas; Namita Murthy; Grégory Effantin; Andrey V Kajava; Alasdair C Steven; Juan S Bonifacino; James H Hurley
Journal:  Nature       Date:  2007-09-23       Impact factor: 49.962

3.  Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family.

Authors:  C Wider; L Skipper; A Solida; L Brown; M Farrer; D Dickson; Z K Wszolek; F J G Vingerhoets
Journal:  Parkinsonism Relat Disord       Date:  2008-03-14       Impact factor: 4.891

Review 4.  Retromer.

Authors:  Juan S Bonifacino; James H Hurley
Journal:  Curr Opin Cell Biol       Date:  2008-05-09       Impact factor: 8.382

5.  Vps35 mediates vesicle transport between the mitochondria and peroxisomes.

Authors:  Emélie Braschi; Vanessa Goyon; Rodolfo Zunino; Abhishek Mohanty; Liqun Xu; Heidi M McBride
Journal:  Curr Biol       Date:  2010-07-08       Impact factor: 10.834

6.  Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation.

Authors:  Alim Muhammad; Ingrid Flores; Hong Zhang; Rui Yu; Agnieszka Staniszewski; Emmanuel Planel; Mathieu Herman; Lingling Ho; Robert Kreber; Lawrence S Honig; Barry Ganetzky; Karen Duff; Ottavio Arancio; Scott A Small
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

7.  Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy.

Authors:  Kristien Verhoeven; Peter De Jonghe; Katrien Coen; Nathalie Verpoorten; Michaela Auer-Grumbach; Jennifer M Kwon; David FitzPatrick; Eric Schmedding; Els De Vriendt; An Jacobs; Veerle Van Gerwen; Klaus Wagner; Hans-Peter Hartung; Vincent Timmerman
Journal:  Am J Hum Genet       Date:  2003-01-21       Impact factor: 11.025

8.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease.

Authors:  Wataru Satake; Yuko Nakabayashi; Ikuko Mizuta; Yushi Hirota; Chiyomi Ito; Michiaki Kubo; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Masahiko Watanabe; Atsushi Takeda; Hiroyuki Tomiyama; Kenji Nakashima; Kazuko Hasegawa; Fumiya Obata; Takeo Yoshikawa; Hideshi Kawakami; Saburo Sakoda; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Yusuke Nakamura; Tatsushi Toda
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

10.  Targeted capture and massively parallel sequencing of 12 human exomes.

Authors:  Sarah B Ng; Emily H Turner; Peggy D Robertson; Steven D Flygare; Abigail W Bigham; Choli Lee; Tristan Shaffer; Michelle Wong; Arindam Bhattacharjee; Evan E Eichler; Michael Bamshad; Deborah A Nickerson; Jay Shendure
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

View more
  334 in total

Review 1.  Exome sequencing: a transformative technology.

Authors:  Andrew B Singleton
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

Review 2.  Movement disorders in 2011: Translating new research findings into clinical practice.

Authors:  Christine Klein; Dimitri Krainc
Journal:  Nat Rev Neurol       Date:  2011-12-20       Impact factor: 42.937

Review 3.  Update on genetics of parkinsonism.

Authors:  Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  Neurodegener Dis       Date:  2012-01-17       Impact factor: 2.977

Review 4.  Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.

Authors:  Trevor Tyson; Jennifer A Steiner; Patrik Brundin
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

5.  Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease.

Authors:  Barbara Shannon; Alexandra Soto-Ortolaza; Sruti Rayaprolu; Heather D Cannon; Catherine Labbé; Bruno A Benitez; Jiyoon Choi; Timothy Lynch; Magdalena Boczarska-Jedynak; Grzegorz Opala; Anna Krygowska-Wajs; Maria Barcikowska; Jay A Van Gerpen; Ryan J Uitti; Wolfdieter Springer; Carlos Cruchaga; Zbigniew K Wszolek; Owen A Ross
Journal:  Neurobiol Aging       Date:  2014-03-05       Impact factor: 4.673

Review 6.  The genetics of Parkinson's disease: progress and therapeutic implications.

Authors:  Andrew B Singleton; Matthew J Farrer; Vincenzo Bonifati
Journal:  Mov Disord       Date:  2013-01       Impact factor: 10.338

Review 7.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

8.  DNAJC13 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alex Rajput; Austen J Milnerwood; Brinda Shah; Chelsea Szu-Tu; Joanne Trinh; Irene Yu; Mary Encarnacion; Lise N Munsie; Lucia Tapia; Emil K Gustavsson; Patrick Chou; Igor Tatarnikov; Daniel M Evans; Frederick T Pishotta; Mattia Volta; Dayne Beccano-Kelly; Christina Thompson; Michelle K Lin; Holly E Sherman; Heather J Han; Bruce L Guenther; Wyeth W Wasserman; Virginie Bernard; Colin J Ross; Silke Appel-Cresswell; A Jon Stoessl; Christopher A Robinson; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Jan O Aasly; Ruey-Meei Wu; Faycal Hentati; Rachel A Gibson; Peter S McPherson; Martine Girard; Michele Rajput; Ali H Rajput; Matthew J Farrer
Journal:  Hum Mol Genet       Date:  2013-11-11       Impact factor: 6.150

9.  PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family.

Authors:  Simone Olgiati; Anna De Rosa; Marialuisa Quadri; Chiara Criscuolo; Guido J Breedveld; Marina Picillo; Sabina Pappatà; Mario Quarantelli; Paolo Barone; Giuseppe De Michele; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2014-05-10       Impact factor: 2.660

Review 10.  VPS35 Parkinson's disease phenotype resembles the sporadic disease.

Authors:  Walter Struhal; Stefan Presslauer; Sabine Spielberger; Alexander Zimprich; Eduard Auff; Thomas Bruecke; Werner Poewe; Gerhard Ransmayr
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.